Rate and Predictors of Misclassification of Active Diabetic Macular Edema as Detected by an Automated Retinal Image

Lamberto La Franca1, Carola Rutigliani2, Lisa Checchin1

  • 1Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, IRCCS Ospedale San Raffaele, University Vita-Salute, Via Olgettina 60, 20132, Milan, Italy.

PubMed
Abstract

Insights

This study evaluated the automated retinal image analysis system (ARIAS) for diagnosing diabetic macular edema (DME), finding it effective for screening new cases but less reliable for monitoring inactive DME.

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Artificial Intelligence in Healthcare

Background:

  • Diabetic macular edema (DME) is a leading cause of vision loss in diabetic patients.
  • Accurate and timely diagnosis of active DME is crucial for effective treatment and vision preservation.
  • Automated retinal image analysis systems (ARIAS) offer potential for efficient screening and diagnosis.

Purpose of the Study:

  • To assess the sensitivity, specificity, and misclassification rate of ARIAS in detecting active DME.
  • To identify clinical and imaging factors associated with true and false positive diagnoses by ARIAS.

Main Methods:

  • A cross-sectional study involving 298 eyes of diabetic patients referred for DME evaluation.
  • Fundus photography analyzed by ARIAS (EyeArt V.2.1.0).
  • Active DME defined by spectral-domain optical coherence tomography (SD-OCT).

Main Results:

  • ARIAS demonstrated a sensitivity of 82.61% and specificity of 84.47% for active DME.
  • The overall misclassification rate was 16%.
  • Factors like younger age and shorter diabetes duration were linked to true positives, while longer diabetes duration and history of inactivated DME were associated with false positives.

Conclusions:

  • ARIAS is effective for screening treatment-naïve DME but less suitable for monitoring inactive DME.
  • Sensitivity was lower in older patients and those lacking DME-related fundus lesions.
  • Specificity decreased in patients with a history of inactivated DME.

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...